CN Stock MarketDetailed Quotes

Shanghai RAAS Blood Products (002252)

Watchlist
  • 5.54
  • -0.04-0.72%
Market Closed Apr 24 15:00 CST
36.77BMarket Cap23.28P/E (TTM)

Shanghai RAAS Blood Products (002252) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
-10.13%7.35B
-3.54%6.09B
-7.06%3.95B
-2.45%2.01B
2.67%8.18B
6.39%6.31B
9.02%4.25B
-0.33%2.06B
21.27%7.96B
19.87%5.94B
Operating revenue
-10.13%7.35B
-3.54%6.09B
-7.06%3.95B
-2.45%2.01B
2.67%8.18B
6.39%6.31B
9.02%4.25B
-0.33%2.06B
21.27%7.96B
19.87%5.94B
Other operating revenue
196.33%8.43M
----
14.20%1.09M
----
80.85%2.85M
----
9.42%956.97K
----
19.10%1.57M
----
Total operating cost
-5.97%5.64B
1.09%4.53B
-5.48%2.88B
-2.70%1.4B
8.04%5.99B
9.51%4.48B
13.12%3.04B
6.02%1.44B
22.98%5.55B
22.14%4.09B
Operating cost
-5.28%4.6B
2.17%3.83B
-2.11%2.46B
-1.03%1.23B
3.05%4.86B
8.74%3.75B
12.20%2.51B
6.94%1.24B
28.57%4.72B
26.88%3.45B
Operating tax surcharges
-4.98%48.63M
-12.83%35.55M
-21.82%23.47M
-22.54%9.58M
35.77%51.18M
43.97%40.78M
51.33%30.03M
42.43%12.36M
14.89%37.69M
32.25%28.33M
Operating expense
-17.97%334.81M
-3.79%241.14M
-35.51%126.41M
1.61%67.76M
22.28%408.14M
-11.88%250.65M
0.70%196.01M
-21.12%66.68M
-10.53%333.76M
0.18%284.44M
Administration expense
2.05%469.08M
1.81%320.9M
-4.34%199.26M
-6.48%89.4M
21.29%459.66M
25.67%315.18M
27.31%208.3M
-1.01%95.59M
13.66%378.98M
6.34%250.81M
Financial expense
-20.87%-41.92M
29.10%-43.88M
-245.49%-33.34M
-5.15%-25.88M
62.13%-34.68M
-26.92%-61.9M
31.41%-9.65M
33.38%-24.61M
-121.98%-91.58M
-511.51%-48.77M
-Interest expense (Financial expense)
19,516.19%44.11M
37,911.05%23.34M
12,965.45%5.98M
958.56%228.49K
87.79%224.88K
-27.38%61.4K
-24.60%45.79K
-33.61%21.59K
-54.50%119.75K
-62.02%84.54K
-Interest Income (Financial expense)
42.21%-69.73M
37.38%-56.56M
32.54%-41.18M
28.06%-23.7M
10.88%-120.65M
11.26%-90.33M
9.76%-61.04M
-4.98%-32.95M
-37.71%-135.38M
-53.55%-101.79M
Research and development
-10.97%223.37M
-21.60%149.58M
-4.49%101.26M
-33.98%33.07M
44.42%250.9M
44.04%190.78M
22.05%106.03M
8.84%50.09M
19.24%173.74M
29.74%132.45M
Credit Impairment Loss
27.42%-31.2M
-35.73%-43.56M
-38.91%-29.16M
-481.11%-15.44M
-923.76%-42.98M
-2,780.55%-32.09M
-412.23%-20.99M
-125.07%-2.66M
131.87%5.22M
105.70%1.2M
Asset Impairment Loss
-1,017.01%-149.55M
-228.18%-44.33M
-78.89%-19.74M
-424.01%-3.94M
44.21%-13.39M
-45.13%-13.51M
-345.67%-11.04M
157.10%1.22M
88.45%-24M
-51.11%-9.31M
Other net revenue
-59.55%202.01M
-56.78%186.23M
-55.92%150.42M
-76.12%71.93M
361.85%499.39M
56.80%430.89M
36.79%341.25M
116.78%301.21M
-185.55%-190.72M
-8.88%274.8M
Fair value change income
----
----
----
----
----
----
----
----
-319.57%-40.36M
-227.78%-23.58M
Invest income
-31.29%352.86M
-38.78%269.3M
-42.27%195.9M
-66.37%90.35M
433.83%513.51M
47.34%439.92M
68.58%339.34M
129.31%268.7M
-137.30%-153.82M
-7.74%298.58M
-Including: Investment income associates
5.46%352.86M
3.18%269.3M
22.12%195.9M
0.64%90.35M
312.01%334.59M
-11.40%261M
-18.69%160.42M
-23.38%89.78M
-138.27%-157.82M
-8.98%294.58M
Asset deal income
1,414.61%21.16M
83.42%-265.94K
104.18%48.61K
100.74%8.52K
-12,782.99%-1.61M
-636,116.12%-1.6M
-9,682,141.35%-1.16M
-1,450.67%-1.15M
-105.50%-12.49K
-99.67%252.18
Other revenue
-80.08%8.74M
-86.70%5.08M
-90.38%3.38M
-97.31%945.93K
97.08%43.86M
382.81%38.18M
635.91%35.11M
1,345.89%35.1M
38.91%22.26M
-35.29%7.91M
Operating profit
-28.63%1.91B
-22.87%1.74B
-20.93%1.22B
-26.28%675.2M
20.51%2.68B
6.88%2.26B
6.20%1.55B
8.75%915.96M
-2.35%2.23B
11.30%2.12B
Add:Non operating Income
-68.22%2.63M
939.54%4.8M
159.41%465.7K
75.95%185.59K
242.06%8.27M
-14.93%461.44K
17.00%179.52K
91.24%105.48K
712.15%2.42M
47.21%542.41K
Less:Non operating expense
-84.36%10.93M
-74.22%25.28M
-80.72%15.31M
-60.74%5.09M
195.56%69.91M
1,006.32%98.05M
2,153.26%79.44M
940.15%12.96M
316.59%23.66M
324.35%8.86M
Total profit
-27.27%1.91B
-20.33%1.72B
-17.68%1.21B
-25.78%670.3M
18.87%2.62B
2.67%2.16B
0.99%1.47B
7.37%903.11M
-3.06%2.2B
10.96%2.11B
Less:Income tax cost
-22.84%328.93M
-22.07%253.4M
-21.18%180.09M
-28.73%104.08M
-0.08%426.31M
1.08%325.15M
5.18%228.49M
18.90%146.03M
6.50%426.65M
7.38%321.68M
Net profit
-28.13%1.58B
-20.03%1.47B
-17.03%1.03B
-25.21%566.22M
23.42%2.19B
2.96%1.84B
0.26%1.24B
5.40%757.08M
-5.10%1.78B
11.63%1.79B
Net profit from continuing operation
-28.13%1.58B
-20.03%1.47B
-17.03%1.03B
-25.21%566.22M
23.42%2.19B
2.96%1.84B
0.26%1.24B
5.40%757.08M
-5.10%1.78B
11.63%1.79B
Less:Minority Profit
-184.03%-418.92K
-159.26%-418.92K
-188.03%-235.03K
-45.75%141.82K
124.39%498.54K
135.59%706.99K
123.09%266.98K
186.54%261.39K
71.18%-2.04M
53.35%-1.99M
Net profit of parent company owners
-28.10%1.58B
-19.97%1.47B
-17.00%1.03B
-25.20%566.08M
23.25%2.19B
2.81%1.84B
0.15%1.24B
5.32%756.82M
-5.35%1.78B
11.46%1.79B
Earning per share
Basic earning per share
-27.27%0.24
-19.86%0.222
-17.11%0.155
-25.44%0.085
22.22%0.33
4.14%0.277
1.63%0.187
6.54%0.114
-3.57%0.27
11.76%0.266
Diluted earning per share
-27.27%0.24
-19.86%0.222
-17.11%0.155
-25.44%0.085
22.22%0.33
4.14%0.277
1.63%0.187
6.54%0.114
-3.57%0.27
11.76%0.266
Other composite income
-238.78%-267.77M
31.68%-104.81M
-93.40%4.81M
-99.35%312.92K
-28.90%192.95M
-133.57%-153.41M
-87.16%72.94M
125.21%47.95M
-77.83%271.39M
-68.88%456.98M
Other composite income of parent company owners
-238.78%-267.77M
31.68%-104.81M
-93.40%4.81M
-99.35%312.92K
-28.90%192.95M
-133.57%-153.41M
-87.16%72.94M
125.21%47.95M
-77.83%271.39M
-68.88%456.98M
Total composite income
-45.16%1.31B
-18.97%1.37B
-21.27%1.03B
-29.62%566.54M
16.49%2.39B
-24.86%1.69B
-27.24%1.31B
52.45%805.02M
-33.84%2.05B
-26.91%2.24B
Total composite income of parent company owners
-45.13%1.31B
-18.91%1.37B
-21.24%1.03B
-29.62%566.4M
16.35%2.39B
-24.96%1.68B
-27.30%1.31B
52.31%804.76M
-33.93%2.05B
-26.95%2.24B
Total composite income of minority owners
-184.03%-418.92K
-159.26%-418.92K
-188.03%-235.03K
-45.75%141.82K
124.39%498.54K
135.59%706.99K
123.09%266.98K
186.54%261.39K
71.18%-2.04M
53.35%-1.99M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue -10.13%7.35B-3.54%6.09B-7.06%3.95B-2.45%2.01B2.67%8.18B6.39%6.31B9.02%4.25B-0.33%2.06B21.27%7.96B19.87%5.94B
Operating revenue -10.13%7.35B-3.54%6.09B-7.06%3.95B-2.45%2.01B2.67%8.18B6.39%6.31B9.02%4.25B-0.33%2.06B21.27%7.96B19.87%5.94B
Other operating revenue 196.33%8.43M----14.20%1.09M----80.85%2.85M----9.42%956.97K----19.10%1.57M----
Total operating cost -5.97%5.64B1.09%4.53B-5.48%2.88B-2.70%1.4B8.04%5.99B9.51%4.48B13.12%3.04B6.02%1.44B22.98%5.55B22.14%4.09B
Operating cost -5.28%4.6B2.17%3.83B-2.11%2.46B-1.03%1.23B3.05%4.86B8.74%3.75B12.20%2.51B6.94%1.24B28.57%4.72B26.88%3.45B
Operating tax surcharges -4.98%48.63M-12.83%35.55M-21.82%23.47M-22.54%9.58M35.77%51.18M43.97%40.78M51.33%30.03M42.43%12.36M14.89%37.69M32.25%28.33M
Operating expense -17.97%334.81M-3.79%241.14M-35.51%126.41M1.61%67.76M22.28%408.14M-11.88%250.65M0.70%196.01M-21.12%66.68M-10.53%333.76M0.18%284.44M
Administration expense 2.05%469.08M1.81%320.9M-4.34%199.26M-6.48%89.4M21.29%459.66M25.67%315.18M27.31%208.3M-1.01%95.59M13.66%378.98M6.34%250.81M
Financial expense -20.87%-41.92M29.10%-43.88M-245.49%-33.34M-5.15%-25.88M62.13%-34.68M-26.92%-61.9M31.41%-9.65M33.38%-24.61M-121.98%-91.58M-511.51%-48.77M
-Interest expense (Financial expense) 19,516.19%44.11M37,911.05%23.34M12,965.45%5.98M958.56%228.49K87.79%224.88K-27.38%61.4K-24.60%45.79K-33.61%21.59K-54.50%119.75K-62.02%84.54K
-Interest Income (Financial expense) 42.21%-69.73M37.38%-56.56M32.54%-41.18M28.06%-23.7M10.88%-120.65M11.26%-90.33M9.76%-61.04M-4.98%-32.95M-37.71%-135.38M-53.55%-101.79M
Research and development -10.97%223.37M-21.60%149.58M-4.49%101.26M-33.98%33.07M44.42%250.9M44.04%190.78M22.05%106.03M8.84%50.09M19.24%173.74M29.74%132.45M
Credit Impairment Loss 27.42%-31.2M-35.73%-43.56M-38.91%-29.16M-481.11%-15.44M-923.76%-42.98M-2,780.55%-32.09M-412.23%-20.99M-125.07%-2.66M131.87%5.22M105.70%1.2M
Asset Impairment Loss -1,017.01%-149.55M-228.18%-44.33M-78.89%-19.74M-424.01%-3.94M44.21%-13.39M-45.13%-13.51M-345.67%-11.04M157.10%1.22M88.45%-24M-51.11%-9.31M
Other net revenue -59.55%202.01M-56.78%186.23M-55.92%150.42M-76.12%71.93M361.85%499.39M56.80%430.89M36.79%341.25M116.78%301.21M-185.55%-190.72M-8.88%274.8M
Fair value change income ---------------------------------319.57%-40.36M-227.78%-23.58M
Invest income -31.29%352.86M-38.78%269.3M-42.27%195.9M-66.37%90.35M433.83%513.51M47.34%439.92M68.58%339.34M129.31%268.7M-137.30%-153.82M-7.74%298.58M
-Including: Investment income associates 5.46%352.86M3.18%269.3M22.12%195.9M0.64%90.35M312.01%334.59M-11.40%261M-18.69%160.42M-23.38%89.78M-138.27%-157.82M-8.98%294.58M
Asset deal income 1,414.61%21.16M83.42%-265.94K104.18%48.61K100.74%8.52K-12,782.99%-1.61M-636,116.12%-1.6M-9,682,141.35%-1.16M-1,450.67%-1.15M-105.50%-12.49K-99.67%252.18
Other revenue -80.08%8.74M-86.70%5.08M-90.38%3.38M-97.31%945.93K97.08%43.86M382.81%38.18M635.91%35.11M1,345.89%35.1M38.91%22.26M-35.29%7.91M
Operating profit -28.63%1.91B-22.87%1.74B-20.93%1.22B-26.28%675.2M20.51%2.68B6.88%2.26B6.20%1.55B8.75%915.96M-2.35%2.23B11.30%2.12B
Add:Non operating Income -68.22%2.63M939.54%4.8M159.41%465.7K75.95%185.59K242.06%8.27M-14.93%461.44K17.00%179.52K91.24%105.48K712.15%2.42M47.21%542.41K
Less:Non operating expense -84.36%10.93M-74.22%25.28M-80.72%15.31M-60.74%5.09M195.56%69.91M1,006.32%98.05M2,153.26%79.44M940.15%12.96M316.59%23.66M324.35%8.86M
Total profit -27.27%1.91B-20.33%1.72B-17.68%1.21B-25.78%670.3M18.87%2.62B2.67%2.16B0.99%1.47B7.37%903.11M-3.06%2.2B10.96%2.11B
Less:Income tax cost -22.84%328.93M-22.07%253.4M-21.18%180.09M-28.73%104.08M-0.08%426.31M1.08%325.15M5.18%228.49M18.90%146.03M6.50%426.65M7.38%321.68M
Net profit -28.13%1.58B-20.03%1.47B-17.03%1.03B-25.21%566.22M23.42%2.19B2.96%1.84B0.26%1.24B5.40%757.08M-5.10%1.78B11.63%1.79B
Net profit from continuing operation -28.13%1.58B-20.03%1.47B-17.03%1.03B-25.21%566.22M23.42%2.19B2.96%1.84B0.26%1.24B5.40%757.08M-5.10%1.78B11.63%1.79B
Less:Minority Profit -184.03%-418.92K-159.26%-418.92K-188.03%-235.03K-45.75%141.82K124.39%498.54K135.59%706.99K123.09%266.98K186.54%261.39K71.18%-2.04M53.35%-1.99M
Net profit of parent company owners -28.10%1.58B-19.97%1.47B-17.00%1.03B-25.20%566.08M23.25%2.19B2.81%1.84B0.15%1.24B5.32%756.82M-5.35%1.78B11.46%1.79B
Earning per share
Basic earning per share -27.27%0.24-19.86%0.222-17.11%0.155-25.44%0.08522.22%0.334.14%0.2771.63%0.1876.54%0.114-3.57%0.2711.76%0.266
Diluted earning per share -27.27%0.24-19.86%0.222-17.11%0.155-25.44%0.08522.22%0.334.14%0.2771.63%0.1876.54%0.114-3.57%0.2711.76%0.266
Other composite income -238.78%-267.77M31.68%-104.81M-93.40%4.81M-99.35%312.92K-28.90%192.95M-133.57%-153.41M-87.16%72.94M125.21%47.95M-77.83%271.39M-68.88%456.98M
Other composite income of parent company owners -238.78%-267.77M31.68%-104.81M-93.40%4.81M-99.35%312.92K-28.90%192.95M-133.57%-153.41M-87.16%72.94M125.21%47.95M-77.83%271.39M-68.88%456.98M
Total composite income -45.16%1.31B-18.97%1.37B-21.27%1.03B-29.62%566.54M16.49%2.39B-24.86%1.69B-27.24%1.31B52.45%805.02M-33.84%2.05B-26.91%2.24B
Total composite income of parent company owners -45.13%1.31B-18.91%1.37B-21.24%1.03B-29.62%566.4M16.35%2.39B-24.96%1.68B-27.30%1.31B52.31%804.76M-33.93%2.05B-26.95%2.24B
Total composite income of minority owners -184.03%-418.92K-159.26%-418.92K-188.03%-235.03K-45.75%141.82K124.39%498.54K135.59%706.99K123.09%266.98K186.54%261.39K71.18%-2.04M53.35%-1.99M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Ernst & Young Huaming Accounting Firm (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More